Preferred Label : gene fusion;
MeSH definition : The GENETIC RECOMBINATION of the parts of two or more GENES resulting in a gene with
different or additional regulatory regions, or a new chimeric gene product. ONCOGENE
FUSION includes an ONCOGENE as at least one of the fusion partners and such gene fusions
are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS.
ARTIFICIAL GENE FUSION is carried out in vitro by RECOMBINANT DNA technology.;
MeSH synonym : fusion, gene; fusions, gene; gene fusions;
MeSH annotation : ARTIFICIAL GENE FUSION is also available;
Origin ID : D050939;
UMLS CUI : C0178648;
Allowable qualifiers
Currated CISMeF NLP mapping
Record concept(s)
See also
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
The GENETIC RECOMBINATION of the parts of two or more GENES resulting in a gene with
different or additional regulatory regions, or a new chimeric gene product. ONCOGENE
FUSION includes an ONCOGENE as at least one of the fusion partners and such gene fusions
are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS.
ARTIFICIAL GENE FUSION is carried out in vitro by RECOMBINANT DNA technology.
https://www.has-sante.fr/portail/jcms/c_2774575/fr/evaluation-de-l-acte-de-recherche-ou-de-quantification-du-gene-de-fusion-bcr-abl-par-rt-pcr-dans-le-diagnostic-et-le-suivi-therapeutique-des-leucemies-myeloides-chroniques-et-des-leucemies-lymphoblastiques-aigues
2017
false
false
false
France
French
health technology assessment
leukaemia
lymphoblast
evaluation studies as topic
fusion, nos
reverse transcriptase polymerase chain reaction
precursor cell lymphoblastic Leukemia-Lymphoma
leukemia, myeloid, acute
evaluation research
drug monitoring
no diagnosis
therapeutics
chronic myeloid leukemia
gene fusion
diagnosis
genes, abl
gene, nos
leukemia, myelogenous, chronic, bcr-abl positive
therapeutics
diagnosis
---